Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reversible cardiomyopathies.

Rangadham Nagarakanti1, David Whellan, Sharon Rubin

  • 1Lankenau Institute for Medical Research, Wynnewood, Pennsylvania, USA.

Cardiology in Review
|June 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabis Use and the Risk of Arrhythmias: Insights From a Large Retrospective Multicenter Analysis.

Journal of cardiovascular electrophysiology·2025
Same author

Heart's Hidden Signal: A Rare Case of Alternating Bundle Branch Block and Atrioventricular Block.

JACC. Case reports·2025
Same author

Quantitative cardiac magnetic resonance standardized signal intensity comparison in dilated cardiomyopathy vs. cardiac sarcoidosis.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

S100A1ct: A Synthetic Peptide Derived From S100A1 Protein Improves Cardiac Performance and Survival in Preclinical Heart Failure Models.

Circulation·2024
Same author

Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction.

JACC. Heart failure·2023
Same author

Heart failure 'the cancer of the heart': the prognostic role of the HLM score.

ESC heart failure·2023
Same journal

Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection.

Cardiology in review·2026
Same journal

Cerebrovascular Disease in Pregnancy: Epidemiology, Pathophysiology, Risk Factors, Diagnostic and Management Considerations, Long-Term Maternal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Immunometabolism in Cardiovascular Disease: Linking Metabolic Reprogramming to Inflammation, Atherothrombosis, and Clinical Outcomes.

Cardiology in review·2026
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
See all related articles

Cardiomyopathy, a leading cause of heart failure, includes potentially reversible nonischemic types. Early diagnosis of heart failure etiology is crucial for better prognosis and treatment.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Cardiomyopathy encompasses diverse myocardial disorders leading to cardiac dysfunction.
  • Heart failure prevalence is high and increasing, with cardiomyopathy being a leading cause of hospitalization in older adults.
  • Cardiomyopathy contributes significantly to healthcare costs and lost productivity.

Purpose of the Study:

  • To highlight the prevalence and significance of nonischemic cardiomyopathy.
  • To emphasize the importance of early and precise diagnosis for prognosis and treatment.
  • To underscore the better prognosis associated with reversible nonischemic cardiomyopathies.

Main Methods:

  • Review of epidemiological data and clinical trial findings.
  • Analysis of the prevalence of ischemic versus nonischemic cardiomyopathy.

Related Experiment Videos

  • Examination of prognostic differences based on cardiomyopathy etiology.

    • Main Results:

    • Cardiomyopathy affects millions, causing significant healthcare burden.
    • Ischemic cardiomyopathy constitutes approximately half of cases.
    • Potentially reversible nonischemic cardiomyopathy ranges from 20% to 50% in clinical trials.

    Conclusions:

    • Early and accurate diagnosis of heart failure etiology is critical.
    • Reversible nonischemic cardiomyopathies may have a better prognosis.
    • Understanding cardiomyopathy subtypes informs effective patient management and treatment strategies.